NRX Pharmaceuticals, Inc.
NRXP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001719406
No open-market purchases or sales by NRX Pharmaceuticals, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $47.6M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in NRX Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 38
- +16 vs. Q3 2021
- Shares held
- 2.59M
- +885.0K (+51.8%) vs. Q3 2021
- Total value
- $12.4M
- −$3.44M (−21.7%) vs. Q3 2021
- New holders
- 20
- 9 more added
- Sold out
- 4
- 6 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NRXP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $47.6M |
| Q1 2026 | 33 | $13.2M |
| Q4 2025 | 28 | $14.2M |
| Q3 2025 | 24 | $13.0M |
| Q2 2025 | 25 | $9.76M |
| Q1 2025 | 22 | $4.60M |
| Q4 2024 | 25 | $2.31M |
| Q3 2024 | 18 | $1.21M |
| Q2 2024 | 19 | $1.29M |
| Q1 2024 | 31 | $1.76M |
| Q4 2023 | 30 | $1.84M |
| Q3 2023 | 34 | $964.7K |
| Q2 2023 | 32 | $4.78M |
| Q1 2023 | 30 | $2.07M |
| Q4 2022 | 33 | $3.44M |
| Q3 2022 | 30 | $3.04M |
| Q2 2022 | 37 | $2.18M |
| Q1 2022 | 34 | $25.1M |
| Q4 2021 | 38 | $12.4M |
| Q3 2021 | 23 | $16.2M |
| Q2 2021 | 18 | $18.9M |
| Q1 2021 | 1 | $4.00K |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding NRX Pharmaceuticals, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,172,233 | $5.60M | 0.00% | +172,110+17.2% | Added |
| BlackRock Inc. | 515,448 | $2.46M | 0.00% | +515,448 | New |
| Geode Capital Management, LLC | 211,500 | $1.01M | 0.00% | +165,734+362.1% | Added |
| Susquehanna International Group, LLP | 78,956 | $377.0K | 0.00% | +23,628+42.7% | Added |
| Virtu Financial LLC | 61,583 | $294.0K | 0.03% | +61,583 | New |
| Morgan Stanley | 57,344 | $274.0K | 0.00% | +16,292+39.7% | Added |
| Jane Street Group, LLC | 53,732 | $257.0K | 0.00% | −23,300−30.2% | Reduced |
| Owl Creek Asset Management, L.P. | 50,000 | $239.0K | 0.02% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 44,840 | $214.0K | 0.00% | +1,955+4.6% | Added |
| Wolverine Asset Management LLC | 37,105 | $177.0K | 0.00% | −5,463−12.8% | Reduced |
| Northern Trust Corp | 36,276 | $173.0K | 0.00% | +36,276 | New |
| Squarepoint Ops LLC | 29,496 | $141.0K | 0.00% | +29,496 | New |
| Schonfeld Strategic Advisors LLC | 28,100 | $135.0K | 0.00% | +28,100 | New |
| Alpine Global Management, LLC | 25,326 | $121.0K | 0.02% | +25,326 | New |
| Engineers Gate Manager LP | 25,210 | $121.0K | 0.01% | +25,210 | New |
| Goldman Sachs Group Inc | 19,619 | $94.0K | 0.00% | +19,619 | New |
| Millennium Management LLC | 13,257 | $63.0K | 0.00% | +13,257 | New |
| Wealthcare Advisory Partners LLC | 13,000 | $62.0K | 0.00% | +13,000 | New |
| Charles Schwab Investment Management Inc | 12,000 | $58.0K | 0.00% | +12,000 | New |
| Cubist Systematic Strategies, LLC | 11,773 | $56.0K | 0.00% | +11,773 | New |
| UBS Group AG | 11,742 | $56.0K | 0.00% | +11,742 | New |
| Raymond James Financial Services Advisors, Inc. | 11,567 | $55.0K | 0.00% | +11,567 | New |
| Simplex Trading, LLC | 11,565 | $55.0K | 0.00% | +11,565 | New |
| State Street Corp | 10,300 | $49.0K | 0.00% | +10,300 | New |
| Davenport & Co LLC | 10,000 | $48.0K | 0.00% | +10,000 | New |
| Cutler Group LP | 7,019 | $33.0K | 0.00% | −432−5.8% | Reduced |
| Group One Trading, L.P. | 6,259 | $30.0K | 0.00% | −1,315−17.4% | Reduced |
| JPMorgan Chase & Co | 5,184 | $25.0K | 0.00% | +4,972+2,345.3% | Added |
| Wells Fargo & Company | 5,000 | $24.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,371 | $21.0K | 0.00% | −14,991−77.4% | Reduced |
| Citigroup Inc | 3,342 | $16.0K | 0.00% | +2,863+597.7% | Added |
| Penserra Capital Management LLC | 3,121 | $14.0K | 0.00% | +165+5.6% | Added |
| Marshall Wace, LLP | 2,499 | $12.0K | 0.00% | +2,499 | New |
| Psagot Value Holdings Ltd. / (Israel) | 2,000 | $10.0K | 0.00% | +2,000 | New |
| Quantbot Technologies LP | 1,700 | $8.00K | 0.00% | +135+8.6% | Added |
| Tower Research Capital LLC (TRC) | 219 | $1.00K | 0.00% | −807−78.7% | Reduced |
| Larson Financial Group LLC | 218 | $1.00K | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 172 | $1.00K | 0.00% | +172 | New |
| Cambridge Investment Research Advisors, Inc. | 0 | $0 | 0.00% | −153,523−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −135,087−100.0% | Sold out |
| Murchinson Ltd. | 0 | $0 | 0.00% | −17,900−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| HighPoint Advisor Group LLC | – | – | – | – | Not filed |